US and China agree to a tactical trade truce, suspending port fees and reducing some tariffs, but key issues remain unresolved.
Judge likely to order USDA to use contingency funds to keep some SNAP payments flowing during government shutdown.
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
US and China agree to a tactical trade truce, suspending port fees and reducing some tariffs, but key issues remain unresolved.
Judge likely to order USDA to use contingency funds to keep some SNAP payments flowing during government shutdown.
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
